Schroder Adveq

Portfolio Co Investors 2026 for Schroder Adveq: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Schroder Adveq accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $1.3B. The median disclosed raise is $190M, and the largest is Decibel Therapeutics at $341M, ahead of Bizongo ($257M) and Pliant Therapeutics ($251M).

The names that recur most often on these co-invested cap tables are Schroder Adveq (8 companies), Third Rock Ventures (2 companies), Redalpine (2 companies), BERNINA BioInvest (2 companies), GV (1 company), SR One (1 company). By latest disclosed round, the market skews Series C (2), Series E (1), IPO (1), Series B (1).

Best funded Schroder Adveq companies

  1. Decibel Therapeutics — $341M (latest: Series C)
  2. Bizongo — $257M (latest: Series E)
  3. Pliant Therapeutics — $251M (latest: IPO)
  4. Kuur Therapeutics — $190M
  5. ImmunOs Therapeutics — $89M (latest: Series B)
  6. Memo Therapeutics — $69M (latest: Series C)
  7. Synendos Therapeutics — $31M (latest: Series A)
  8. HAYA Therapeutics — $25M (latest: Seed)

Schroder Adveq — related firms and companies (51)

Schroder Adveq alternatives · All research reports